{[4-(difluoromethoxy)phenyl]methyl}(methyl)amine, 97%, 1g

3,3'-(5'-(3-(Pyridin-3-yl)phenyl)-[1,1':3',1''-terphenyl]-3,3''-diyl)dipyridine, 97%, 25mg

1-(2-chloropyrimidin-5-yl)ethan-1-ol, 95.0%, 500mg

1,4-Bis(chloromethyl)-2-((2-ethylhexyl)oxy)-5-methoxybenzene, 95.0%, 100mg

Methyl 2-bromo-3-phenylpropanoate, 95.0%, 100mg

7-(Trifluoromethyl)chroman-4-amine, 95.0%, 250mg

1,3-Dichloro-5-(3,3,3-trifluoroprop-1-en-2-yl)benzene, 97%, 5g

6-Amino-2-bromo-3-methylbenzoic acid, 95+%, 25g

(S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxaline>98.0%(HPLC)100mg

3-G1F 2AB (500pmol/vial)>95.0%(HPLC)1vial

Methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate, 97%, 10g

2-[1-(tert-Butoxycarbonyl)azetidin-3-yl]acetic Acid>98.0%(GC)(T)1g

ethyl 5-amino-1-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g